$LWLG A few comments on the most recent press releases. If
$LWLG A few comments on the most recent press releases. If you look at them together, you'll see that tremendous progress has been made in the past half year or so.
Mar 26, 2018
Lightwave Logic Successfully Demonstrates Packaged Polymer Modulators Designed for 50Gbps
Successfully completed prototypes of 50Gbps modulator. Exceeded expectations for a 25Gbps modulator. Ahead of schedule plus the opportunity to optimize
Apr 10, 2018
Lightwave Logic CEO Dr. Michael Lebby Voted Winner of the "PIC Entrepreneur and Business Leader" Award at the PIC International Conference in Brussels, Belgium
Oh wow. Won a prize at one of the most important conferences for photonics in the world. LWLG and Lebby are increasingly recognized by other organizations. Compare that to 2 or 3 years ago.
Jun 15, 2018
Lightwave Logic Acquires the Polymer Technology Intellectual Property Assets of BrPhotonics
Acquisition of assets to help optimize packaging for customer prototypes. All done for cheap. Plus patents and 15 polymer materials.
Jun 20, 2018
Lightwave Logic to Solidify Polymer PICs as Part of the Photonics Roadmap at the World Technology Mapping Forum in Europe
If you look at those external presentations that Proto linked to Lightwave is now established on the map and they are using our language to address both the benefits and the industry needs.
Its a huge deal as expectations used to be all over the map and now they can be met by our own product features.
Jul 09, 2018
Dr. Karen Liu, Internationally-Known Analyst and Marketing Executive, Joins Lightwave Logic, Inc.
One of my favorite PRs as of late. Lebby and Lio (and Leonberger) create a diverse team of communicators that are superior to Zelibor and Marcelli.
Nothing against them but its time for the science to lead.
Aug 30, 2018
Lightwave Logic Expands its Capability to Commercialize 50 Gbps Polymer Modulator Platform
Fabrication of wafers is ramping up.
This may mean they anticipate providing customer prototypes requires production capabilities in place. We've already heard the quote about how long it takes for a customer to test a prototype and it is not long at all.
Sep 20, 2018
Lightwave Logic to Present at ECOC and PIC Conferences
"Fundamental technology that allows electro-optic polymers to achieve the target of 100 Gbaud with power-saving low voltage modulation. Polymers are intrinsically suited for a simple hybrid implementation that is synergistic with either Silicon or Indium Phosphide"
Wow. Integrating Silicon and Indium Phosphide into the conversation slides use up much earlier than when it was presented as a stand alone. Huge.
Lightwave Logic is over delivering, speeding up the schedule, and showing results to the shareholders nearly every month. I'm impressed.
Clearly a ways to go, but it looks better than ever before. I think Lebby has promised at least 20 times that the prototypes will be in the hands of potential customers on time.
- jssdmm
Lightwave Logic Inc (LWLG) Stock Research Links
$MJ
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...
Continue Reading
Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...
Continue Reading
Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...
Continue Reading
Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...
Continue Reading
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...
Continue Reading
Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...
Continue Reading
Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...
Continue Reading
A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...
Continue Reading
The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...
Continue Reading
Top 5 Most Recently Viewed Articles
Phreesia to Release Fiscal Q3 2025 Results Soon Phreesia, Inc. (NYSE: PHR) has great news for its stakeholders! The company revealed plans to announce its financial results for the third quarter of fiscal year 2025 right after market closing on a Monday in December. During this quarter, the firm experienced substantial growth and is eager to share the details with the...
Continue Reading
Revolutionary Pet Water Bowl Crafted for Optimal Hydration Every pet owner knows the importance of keeping their furry friends hydrated, especially during hot days. A new invention promises to enhance the experience for pets and their owners alike. This innovative water bowl, known as the THERMA DRINK, is designed with features that cater directly to pet needs. The idea...
Continue Reading
Leadership Transitions at HPH Highest Performances Holdings Inc. (NASDAQ: HPH) has recently seen a notable change in its Board of Directors. The company announced that Mr. Peh Chin Hua's tenure as Director has come to an end, effective immediately. This decision is part of a broader strategy aimed at strengthening the Board's overall composition and capabilities. Current...
Continue Reading
Apranga Group Retail Performance Overview for 2025 Apranga Group, a major player in the retail sector, has announced its impressive financial performance for the first six months of 2025, demonstrating notable growth compared to the prior year. The company's retail turnover reached a commendable EUR 166.1 million, reflecting a 2.8% increase from the same period in 2024....
Continue Reading
New Vaccine Insights from IMUNON's Phase 1 Clinical Trial The innovative PlaCCine technology platform developed by IMUNON, Inc. (NASDAQ: IMNN) promises remarkable durability and advantages over traditional mRNA vaccines, particularly in the struggle against COVID-19. Robust Results from IMNN-101 Vaccine Trials In an encouraging announcement, IMUNON shared pivotal data...
Continue Reading